
Sign up to save your podcasts
Or


This episode explores the latest advancements in personalized DNA and RNA technologies for early cancer detection, diagnostics, and treatment monitoring. Dr. Nathan Montgomery from Neo Genomics Laboratories discusses how molecular residual disease testing, liquid biopsies, and genomic sequencing are transforming oncology care.
By Kevin Folta4.8
273273 ratings
This episode explores the latest advancements in personalized DNA and RNA technologies for early cancer detection, diagnostics, and treatment monitoring. Dr. Nathan Montgomery from Neo Genomics Laboratories discusses how molecular residual disease testing, liquid biopsies, and genomic sequencing are transforming oncology care.

32,246 Listeners

6,881 Listeners

30,609 Listeners

43,687 Listeners

9,238 Listeners

4,022 Listeners

2,053 Listeners

599 Listeners

756 Listeners

3,648 Listeners

12,130 Listeners

818 Listeners

6,467 Listeners

113,121 Listeners

4,167 Listeners